Picture of Acumen Pharmaceuticals logo

ABOS — Acumen Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results, Business Highlights

Nov 14 (Reuters) - Acumen Pharmaceuticals Inc  ABOS.O :
    * ACUMEN PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * ACUMEN PHARMACEUTICALS INC- CASH, CASH EQUIVALENTS &
MARKETABLE
SECURITIES AS OF SEPT. 30 EXPECTED TO FUND CLINICAL AND
OPERATIONAL GOALS THROUGH 2025
    * ACUMEN PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.26

Source text for Eikon:  ID:nGNX1SNrv7 
Further company coverage:  ABOS.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Acumen Pharmaceuticals

See all news